Company: ARTL
Filing Date: 2025-03-03
Form Type: 10-K
Source: 0001640334-25-000335
Chunk: 497

Company: ARTELO BIOSCIENCES, INC.
Filing Date: 2025-03-03
Form: 10-K
Item: Item 1C
Chunk 497
---
 by Douglas Blayney, M.D. exercisable within 60 days of February 27, 2025.(5)Consists of 834 shares held by R. Marty Emanuele, Ph.D., (ii) 4,732 shares of common stock issuable pursuant to options held directly by R. Marty Emanuele, Ph.D. exercisable within 60 days of February 27, 2025.(6)Consists of 3,998 shares of common stock issuable pursuant to options held directly by Gregory R. Reyes M.D., Ph.D. exercisable within 60 days of February 27, 2025.(7)Consists of 1,834 shares of common stock issuable pursuant to options held directly by Tamara A. Favorito exercisable within 60 days of February 27, 2025.

 78Table of contents

Equity Compensation Plan Information

The following table summarizes information about our equity compensation plans as of December 31, 2024. All outstanding option awards relate to our common stock.

Plan Category Number of Securities tobe Issued UponExerciseof OutstandingOptions,Warrants andRights   Weighted- averageExercise Price ofOutstandingOptions,Warrants andRights   Number of Securities Remaining Available forFuture Issuance UnderEquity CompensationPlans(excluding securitiesreflected incolumn (a))    (a)  (b)  (c) Equity compensation plans approved by security holders:         2018 Equity Incentive Plan(1)  773,605  $1.84   755,618 Equity compensation plans not approved by security holders  -   -   - Total  773,605  $1.84   755,618 

(1)Our Board adopted, and our stockholders approved, our 2018 Plan. The 2018 Plan provides that the number of shares available for issuance under the 2018 Plan will be increased on the first day of each fiscal year beginning with the 2021 fiscal year, in an amount equal to the least of (i) 7,500,000 shares (subject to the reverse stock split), (ii) fifteen (15%) of the outstanding shares on the last day of the immediately preceding fiscal year or (iii) such other amount of shares determined by our board. 

 79Table of contents

Changes in Control

We are unaware of any contract or other